known to give the biggest pulse of all
GLP-1 Effect on Dyslipidemia Weight is a contributing factor in increasing patients cardiovascular risk, and many antidiabetic agents available are associated with weight gain or other cardiovascular problems
"We don't know what the excipients are - that is the other ingredients, which come with the medication, which could be potentially toxic and harmful, [or] cause an anaphylactic reaction, allergies and I guess at worse, significant health problems and perhaps even death," she says
The study, published in the Lancet, lasted 68 weeks and followed 667 participants
While most devices only report prandial (i.e., bolus) insulin as IOB, people with type 1 diabetes who are using any kind of continuous subcutaneous insulin infusion (CSII) device can see how much insulin the pump calculates is on board. When insulin basal rate reductions are started approximately 90120 min prior to the start of endurance activity (129), especially in the morning before the first meal (130), significant hypoglycemia protection is achieved for individuals on standard CSII medication
00243-1/asset/23df9500-d21e-4a61-9bfa-1536b8dc9f75/main.assets/gr4a_lrg.jpg)
